19 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... Empiric #Coverage #InfectiousDiseases ... #Pharmacology # ... Management
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
#IDSA #Meningitis ... Pathogens #Isolated #InfectiousDiseases ... #Pharmacology # ... Management
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... ivermectin… #COVID19 ... Pandemic #Outbreak #InfectiousDiseases ... EmergencyMedicine #Pharmacology ... Virus #Antiviral #Management
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... investigated for COVID ... CoronaVirus #Treatment #Management ... Pandemic #Outbreak #InfectiousDiseases ... Pharmacotherapy #Pharmacology
Hydroxychloroquine and Chloroquine in COVID19

Dosing:
Hydroxychloroquine:
 - 400mg PO BID on the first day, followed by 200mg
Chloroquine in COVID19 ... : - 400mg PO BID ... #Chloroquine #COVID19 ... #HCQ #Pharmacology ... #Management #Medications
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
treatments for COVID ... Zithromax #Macrolides #InfectiousDiseases ... #COVID19 #Coronavirus ... #Treatment #Management ... #Pharmacology #
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... (IDSA 2021): ... Fidaxomicin 200 mg PO bid ... /severe CDI IDSA ... #treatment #infectiousdiseases
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... itraconazolea 200 mg PO BID ... Penicilliosis #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... IsosporaBelli #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... candida #mucosal #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology